International Journal of Women''s Dermatology最新文献

{"title":"Deodorant/antiperspirant use and hair removal practices for hidradenitis suppurativa: recommendations from a single-center survey.","authors":"Brett Cutler, Erika Hagstrom, Teri M Greiling","doi":"10.1097/JW9.0000000000000028","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000028","url":null,"abstract":"Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder that frequently affects the axillae. Axillae are also tar-geted for societal hygiene practices: namely, the use of deodor- ants and antiperspirants and techniques for hair removal. HS is associated with an increased risk of hyperhidrosis and female hirsutism due to polycystic ovarian disease, further increasing the impact of these practices on quality of life. 1,2 Patients with HS are often unsure how to appropriately target physiologi- cal body odor and hair removal without worsening their HS. A 1982 case-control study concluded simply that deodorant, shaving, and chemical depilatories are not causative of HS, 3 but little guidance beyond this is available for patients or their providers.","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"9 1","pages":"e028"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/09/jw9-9-e028.PMC9833445.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9178571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of lichen sclerosus and morphea with immune checkpoint therapy: a systematic review.","authors":"Leah Shin, Janellen Smith, Jessica Shiu, Christina N Kraus, Ashley N Elsensohn","doi":"10.1097/JW9.0000000000000070","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000070","url":null,"abstract":"The use of immune checkpoint inhibitors (ICIs) has been asso- ciated with various cutaneous immune-related adverse events (irAEs), including eczematous, psoriasiform, lichenoid, and bul- lous dermatoses. 1,2 Here, we evaluated reports of lichen sclerosus (LS) and morphea associated with ICIs. A literature search was conducted October 7, 2022 of PubMed, Cochrane, Embase, CINAHL, and Web of Science. Search terms: “lichen sclerosus,” “scleroderma, localized,” “mor-phea,” “immune checkpoint inhibitor,” “immunotherapy,” “ipili- mumab,” “nivolumab,” “pembrolizumab,” “atezolizumab,” avelumab,” “durvalumab,” “cemiplimab,” “dostarlimab,” and “relatlimab,” yielding 318 studies. Titles, abstracts, and full-text manuscripts were screened for relevance. Twenty-three studies were included","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"9 1","pages":"e070"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/e4/jw9-9-e070.PMC9851696.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9191205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A rare case of viral-associated trichodysplasia spinulosa in a patient with chronic lymphocytic leukemia.","authors":"Rachel Choi, Shaman Bhullar, Jennifer McNiff, Justin Persico, Jonathan Leventhal","doi":"10.1097/JW9.0000000000000069","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000069","url":null,"abstract":"Viral-associated trichodysplasia spinulosa (VATS) is a cuta- neous eruption of folliculo-centric shiny papules and alo-pecia that most commonly occurs in transplant recipient patients. 1 Here, we present an extremely rare case of VATS in a female patient with chronic lymphocytic leukemia (CLL). An informed consent was obtained from the patient for this report.A 63-year-old female presented with a 2-month history of multiple reddish-pinkish papules on her face in the setting of long-standing CLL. Physical examination also showed leonine facies, superciliary madarosis","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"9 1","pages":"e069"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9170983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vulvar allergic contact dermatitis to multiple acrylates: a case report.","authors":"Núria Riera-Martí, Vicente Expósito-Serrano, Maria Sin, Marta Gamissans, Cristina López-Llunell, Miquel Ribera","doi":"10.1097/JW9.0000000000000077","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000077","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"9 1","pages":"e077"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d3/46/jw9-9-e077.PMC9997830.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9453741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey.","authors":"Ogechi Ezemma, Shivali Devjani, Aidan Lee, Kristen J Kelley, Lisa Anderson, Nicole Friedland, Maryanne Senna","doi":"10.1097/JW9.0000000000000075","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000075","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"9 1","pages":"e075"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/24/jw9-9-e075.PMC9916017.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10697999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A cross-sectional study of contact allergens in feminine hygiene wipes: a possible cause of vulvar contact dermatitis.","authors":"Jazmin Newton,&nbsp;Sophie Richardson,&nbsp;Annika M van Oosbre,&nbsp;Jiade Yu,&nbsp;Channi Silence","doi":"10.1097/JW9.0000000000000060","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000060","url":null,"abstract":"<p><p>Feminine hygiene wipes marketed toward women for maintaining freshness and cleanliness of the vulva and perineum are abundant both in-store and online. Many of these products boast being \"fragrance free,\" \"gentle,\" and \"for sensitive skin,\" which is attractive to consumers. However, these claims do not necessarily mean they are free of potential allergens.</p><p><strong>Objective: </strong>The present study aims to investigate the presence and prevalence of potential allergens in the most used feminine hygiene wipes.</p><p><strong>Methods: </strong>An internet-based search was performed to identify best-selling name brand and generic feminine hygiene wipes. Each unique wipe was analyzed and compared to the North American Contact Dermatitis Group 80 allergens.</p><p><strong>Results: </strong>We found contact allergens are frequently present in feminine hygiene wipes, most commonly fragrances, other scented botanicals in the form of essences, oils, and fruit juices, and vitamin E (tocopherol). All wipes analyzed in this study contained potential allergens.</p><p><strong>Limitations: </strong>The inability to eliminate commercial names from analysis could have introduced bias.</p><p><strong>Conclusions: </strong>Vaginal and vulvar epithelia are highly susceptible to contact allergens, often found in products marketed for feminine hygiene and cleanliness. Providers should caution patients against trusting product labeling claims to avoid incidental contact allergy and encourage simply cleansing the vulva with water.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e060"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10463330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cognitive behavior therapy as dermatological treatment: a narrative review.","authors":"Rishab R Revankar,&nbsp;Nikita R Revankar,&nbsp;Esther A Balogh,&nbsp;Heli A Patel,&nbsp;Sebastian G Kaplan,&nbsp;Steven R Feldman","doi":"10.1097/JW9.0000000000000068","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000068","url":null,"abstract":"<p><p>Cognitive behavior therapy (CBT) is efficacious in treating numerous psychological disorders. It is also effective in combination with medication for chronic pain, diabetes, and other diseases. Patients with skin disease report high levels of stress, anxiety, and negative feelings.</p><p><strong>Objective: </strong>To summarize the findings on the utility of CBT for the improvement of skin status and quality of life in patients with dermatological conditions.</p><p><strong>Methods: </strong>PubMed and Google Scholar databases were searched for relevant articles from database inception to the time of search (October 20, 2021). A total of 30 included studies featured 10 on psoriasis, 11 on atopic dermatitis, 4 on vitiligo, 4 on acne, and 1 study on alopecia areata.</p><p><strong>Results: </strong>Several studies, including randomized controlled trials with large study samples, support the effectiveness of CBT and Internet CBT for a number of dermatological conditions. Patients who completed CBT courses were less likely to rely on dermatological healthcare during follow-up.</p><p><strong>Limitations: </strong>There are a limited number of studies discussing the implementation of CBT for alopecia, acne, and vitiligo.</p><p><strong>Conclusion: </strong>Patients who underwent CBT or Internet CBT in addition to skin care demonstrated improvement with quality of life and severity of skin disease as compared to controls only receiving standard of care treatment.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e068"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/38/jw9-8-e068.PMC9788967.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10856510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccine.","authors":"Aaron J Frederiks,&nbsp;Rachael S Foster,&nbsp;Bernadette Ricciardo","doi":"10.1097/JW9.0000000000000066","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000066","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e066"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/82/jw9-8-e066.PMC9746224.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10456799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating primary palliative care into hidradenitis suppurativa management.","authors":"Terri Shih,&nbsp;Monica Zell,&nbsp;Daniel Karlin,&nbsp;Devea R De,&nbsp;Jan Smogorzewski,&nbsp;Vivian Y Shi,&nbsp;Jennifer L Hsiao","doi":"10.1097/JW9.0000000000000063","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000063","url":null,"abstract":"<p><p>Hidradenitis suppurativa (HS) is a chronic, often debilitating skin condition that disproportionately impacts women in the United States and other Western nations. Dermatologists should consider incorporating palliative care principles into HS management to optimize care. Primary palliative care principles include utilizing evidence-based frameworks in serious illness communication, acknowledging and addressing physical and psychosocial suffering, recognizing and validating the burden of disease in partners, families, and caregivers, and engaging in collaborative care coordination. Certain patients may also benefit from outpatient, or sometimes inpatient, palliative care specialist collaboration, such as those with refractory HS and superimposed challenging psychosocial dynamics and symptom burden. Through integration of these palliative care domains into HS care, dermatologists can optimize their ability to provide comprehensive and compassionate care for patients suffering with this disease.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e063"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/82/jw9-8-e063.PMC9760599.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10456813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alopecia areata incognita: clinical characteristics and use of the Sinclair shedding scale.","authors":"Maya S Collins,&nbsp;Shaheir Ali,&nbsp;Kristen Kelley,&nbsp;Maryanne Makredes Senna","doi":"10.1097/JW9.0000000000000067","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000067","url":null,"abstract":"Introduced in 1987, alopecia areata incognita (AAI), is incredibly difficult to diagnose. It presents as persistent, diffuse hair shedding while patients maintain normal hair density.1,2 We report 4 cases of AAI diagnosed in our specialty alopecia clinic, highlighting aspects of the condition that impart high levels of diagnostic suspicion. A chart review conducted between December 2017 and March 2022 yielded 4 patients with AAI. All patients were Caucasian females, average age of 45.3 years (SD = 10.9), with several years of excess scalp hair shedding. They denied telogen effluvium (TE) triggers or patchy hair loss. Initial differential diagnoses included female pattern hair loss (FPHL) and chronic telogen effluvium. Despite diligent treatment with >6 months oral spironolactone and/or oral low dose minoxidil, patients reported no improvement in shedding. All patients were noted to have a distinctive global appearance: normal density of 5–6-cm length terminal hairs on the top of the scalp and dramatically decreased density of longer terminal hairs distally (Fig. 1). Trichoscopy was unrevealing. AAI patients may develop circular patches of classic alopecia areata, but this was not observed in our initial evaluations.2,3 Scalp biopsies in all 4 patients varied with findings and the respective dermatopathologist favored diagnoses are listed in Table 1. Biopsy findings in AAI are subtle and vary depending on the disease stage.4,5 Histopathology in our patients was insufficient for a definitive diagnosis of alopecia areata incognita. Patients with AAI may collect 350–1000 hairs per day using the modified wash test.6 As the modified wash test is notably time consuming and difficult, we utilized the Sinclair shedding scale (SSS) to assess hair shedding.7 All patients reported >Grade 6 daily shedding on the SSS, representing about 750 hairs per day.7 Given our suspicion for AAI, we added monthly intralesional corticosteroid scalp injections at 5 mg/mL doses across the scalp. Patients did not use adjunct topical corticosteroids. After 2 treatment sessions, all patients reported SSS score improvement to the normal range and increased distal hair density (Fig. 1). One patient developed a few patches of subcentimeter classic alopecia areata that subsequently improved. Several AAI publications emphasize diagnosis based on growth phases and trichoscopy.2,3 We highlight an AAI clinical phenotype and demonstrate utility of the SSS when AAI is suspected. Originally developed to aid diagnosis of FPHL, the SSS is useful in assessing the response to treatment in women with varying hair lengths. Given that our patients had straight hair without improved SSS scores despite adequate treatment of FPHL, the SSS provided critical clinical estimates of shedding without extensive effort from patients or providers. The SSS","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e067"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10856512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}